These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 1779879

  • 1. A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.
    Martin MA, Liebana J, Castillo AM, Gutierrez J, Piédrola G.
    Microbios; 1991; 67(272-273):195-202. PubMed ID: 1779879
    [Abstract] [Full Text] [Related]

  • 2. Increase in the activity of third-generation cephalosporins in combination with clavulanic acid and Sulbactam against Bacteroides fragilis.
    Martín MA, Castillo AM, Liebana J, Mesa P, Piedrola G, Gutierrez J.
    Med Lab Sci; 1990 Jul; 47(3):163-7. PubMed ID: 2402195
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA, Castillo AM, Liébana J, Marín A, Alados JC, Piédrola G.
    J Hyg Epidemiol Microbiol Immunol; 1991 Jul; 35(2):189-97. PubMed ID: 1940333
    [Abstract] [Full Text] [Related]

  • 4. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
    Nord CE.
    J Chemother; 1989 Jul; 1(4 Suppl):273-5. PubMed ID: 16312398
    [No Abstract] [Full Text] [Related]

  • 5. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.
    Maskell JP, Nasu M, Williams JD.
    J Antimicrob Chemother; 1984 Jan; 13(1):23-30. PubMed ID: 6607916
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
    Prabhakaran K, Harris EB, Randhawa B, Hastings RC.
    Microbios; 1995 Jan; 81(328):177-85. PubMed ID: 7752957
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME, Fu KP, Gregory FJ, Hung PP.
    Drugs Exp Clin Res; 1987 Jan; 13(3):145-8. PubMed ID: 3040368
    [Abstract] [Full Text] [Related]

  • 11. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P, Soussy CJ, Orsoni A, Brickley X, Duval J.
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [Abstract] [Full Text] [Related]

  • 12. [Comparative bacteriostatic activity of ticarcillin, alone and combined with clavulanic acid, 5 cephalosporins and metronidazole against 100 strains of Bacteroides fragilis].
    de Barbeyrac B, Quentin C, Bebear C.
    Pathol Biol (Paris); 1984 May; 32(5):433-5. PubMed ID: 6739151
    [Abstract] [Full Text] [Related]

  • 13. Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
    Fuchs PC, Jones RN, Barry AL.
    Diagn Microbiol Infect Dis; 1987 Sep; 8(1):61-5. PubMed ID: 3501975
    [Abstract] [Full Text] [Related]

  • 14. Development of beta-lactamase inhibitors.
    Sutherland R.
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [Abstract] [Full Text] [Related]

  • 15. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
    Sanders CV, Aldridge KE.
    J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
    García-Rodríguez JA, García Sánchez JE, Trujillano I, Muñoz-Bellido JL.
    J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 18. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.
    Dornbusch K, Nord CE, Olsson-Liljeqvist B.
    Scand J Infect Dis Suppl; 1979 Feb; (19):17-25. PubMed ID: 37593
    [Abstract] [Full Text] [Related]

  • 19. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL, Monroy E, García O, Vaca S.
    Rev Latinoam Microbiol; 1998 Feb; 40(3-4):128-34. PubMed ID: 10932741
    [Abstract] [Full Text] [Related]

  • 20. Plasmid-related beta-lactamase production in Bacteroides fragilis strains.
    Nakano V, Padilla G, do Valle Marques M, Avila-Campos MJ.
    Res Microbiol; 2004 Dec; 155(10):843-6. PubMed ID: 15567279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.